FDA inspection
Novartis Pharma AG: FDA inspection ending Aug 29, 2019
FDA inspection 1109986 · Voluntary Action Indicated (VAI) · Basel
Key facts
| Inspection ID | 1109986 |
|---|---|
| Firm | Novartis Pharma AG |
| FEI number | 3002807772 |
| Address | Lichtstrasse 35 |
| City | Basel |
| Fiscal year | 2019 |
| Inspection end date | Aug 29, 2019 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | New Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data